These combined findings indicate that the RASopathy- and the cancer-associated MEK1 mutations generate distinct spatio-temporal properties of ERK signaling and thereby differentially alter the global gene expression profiles in cells. This evidence concerns the gene MAP2K1 and RASopathy.